Spark Therapeutics (ONCE) – Hot Comments
-
BioMarin Pharma (BMRN) Should Not Be Selling Off on Heme Data - Citi
-
SunTrust Highlights 3 Stocks That Could Benefit from Novartis's $8.7B Acquisition of AveXis
-
-
-
-
Back to ONCE Stock Lookup